Biohaven (BHVN) Non-Current Assets (2021 - 2026)
Biohaven's (BHVN) quarterly Non-Current Assets came in at $80.8 million in Q1 2026, up 6.0% year-on-year from $76.2 million in Q1 2025, and down 2.84% quarter-over-quarter from $83.1 million in Q4 2025.
Biohaven (BHVN) Non-Current Assets (2021 - 2026) Analysis & Trends
Biohaven has disclosed Non-Current Assets across 6 years of filings, most recently posting $80.8 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $80.8 million, up 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $325.0 million (up 10.45% YoY), and the FY2025 annual result was $83.1 million, up 8.46% from the prior year.
- Non-Current Assets came in at $80.8 million for Q1 2026 at Biohaven, down from $83.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $85.5 million in Q3 2025 to a low of $55.1 million in Q3 2022.
- The 5-year median for Non-Current Assets is $74.0 million (2023), against an average of $73.9 million.
- Across the five-year window, Non-Current Assets soared 58.38% in 2022 and slipped 5.75% in 2024, its largest moves.
- Biohaven's Non-Current Assets stood at $74.8 million in 2022, then dropped by 5.41% to $70.8 million in 2023, then grew by 8.29% to $76.6 million in 2024, then rose by 8.46% to $83.1 million in 2025, then dropped by 2.84% to $80.8 million in 2026.
- The last three Non-Current Assets figures came in at $80.8 million (Q1 2026), $83.1 million (Q4 2025), and $85.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 39.71 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | 80.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.76 Mn |
| Dec 31, 2025 | 83.12 Mn |
| Sep 30, 2025 | 85.51 Mn |
| Jun 30, 2025 | 75.59 Mn |
| Mar 31, 2025 | 76.19 Mn |
| Dec 31, 2024 | 76.64 Mn |
| Sep 30, 2024 | 70.02 Mn |
| Jun 30, 2024 | 71.37 Mn |
| Mar 31, 2024 | 69.79 Mn |
| Dec 31, 2023 | 70.77 Mn |
| Sep 30, 2023 | 72.17 Mn |
| Jun 30, 2023 | 72.62 Mn |
| Mar 31, 2023 | 74.05 Mn |
| Dec 31, 2022 | 74.82 Mn |
| Sep 30, 2022 | 55.10 Mn |
| Dec 31, 2021 | 47.24 Mn |